AI - Freenome
Pioneering early cancer detection through innovative next-generation blood tests using Freenome's multiomics platform.
- Name
- Freenome -https://www.freenome.com/
- Last Audited At
About Freenome
Freenome is a pioneering biotech company that develops next-generation blood tests for early cancer detection. Leveraging their innovative multiomics platform, Freenome is moving early cancer detection forward, making it accessible to all. Based in South San Francisco, the team at Freenome is dedicated to decoding the means to cancer's end through clinical evidence and rigorous research. With a strong focus on accessibility, Freenome's early cancer detection blood tests aim to identify cancer in its earliest, most treatable stages. The company's commitment extends beyond their products, as they actively engage in partnerships and offer career opportunities in the field.
